Targeted Physical Activity for Pancreatic Cancer Patients
This study is looking at a targeted physical exercise program for people with pancreatic cancer who are receiving chemotherapy before surgery (neoadjuvant chemotherapy). This program involves 36 sessions of supervised, individualized physical activity over about 4-5 months. The goal is to see if this exercise program is practical and safe, and to get an early idea of how it might improve physical function. You may be able to join if you are at least 18 years old, have pancreatic cancer that can potentially be removed by surgery, are receiving or planning to receive neoadjuvant chemotherapy, and are considered frail or pre-frail. This study is currently unclear on its status, and aims to enroll 25 participants.
- Study design
- This is an interventional study, meaning participants will receive a specific treatment. It aims to enroll 25 participants.
- What's involved
- You would participate in a 36-session targeted physical exercise program delivered twice weekly, over approximately 18-20 weeks (about 4-5 months). This includes a baseline assessment.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will measure recruitment, retention, and adherence rates at 6 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Pilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Recruitment rate6 months
Defined as the number of participants enrolled divided by the number of eligible patients approached.
- Retention rate6 months
Defined as the proportion of enrolled participants who complete the post-intervention assessment (Session 36 assessment window).
- Adherence rate6 months
Defined as the number of exercise sessions attended divided by 36, is summarized as a continuous measure and as the proportion of participants achieving a prespecified adherence threshold.
- Exercise-related adverse events (AEs) and serious adverse events (SAEs)6 months
Summarized by frequency, severity, and relatedness to study participation, including any events requiring modification, temporary pause, or discontinuation of the exercise program.